Your browser doesn't support javascript.
loading
The Importance of Recency of Cancer Diagnosis in Patients Hospitalized with COVID-19-Glimpses from an EHR-based Study.
Egan, Pamela C; Jani, Chinmay; Singh, Harpreet; Mishra, Sanjay; Warner, Jeremy L.
Afiliação
  • Egan PC; Lifespan Cancer Institute, Providence, Rhode Island.
  • Jani C; Brown University, Providence, Rhode Island.
  • Singh H; Mount Auburn Hospital, Cambridge, Massachusetts.
  • Mishra S; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Warner JL; Lifespan Cancer Institute, Providence, Rhode Island.
Cancer Epidemiol Biomarkers Prev ; 32(1): 3-5, 2023 01 09.
Article em En | MEDLINE | ID: mdl-36620898
Multiple prior studies have shown an increased risk of severe disease and death from SARS-CoV-2 infection in patients with cancer. Nolan and colleagues conducted a multi-institution, electronic health record (EHR)-based study of adults hospitalized with COVID-19 delineating the difference in outcomes when stratified by current versus former cancer diagnosis and found that only a current diagnosis appears to confer an increased risk of severe COVID-19 and death.We review these findings in the context of other studies examining outcomes for individuals with cancer diagnoses and COVID-19. We also address questions raised by this type of study about the significant challenges of EHR-based studies and discuss potential avenues for future research in this arena. See related article by Nolan et al., p. 12.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article